[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Biopsy Devises Market, 2012 to 2023

January 2018 | 220 pages | ID: B298A9DD358EN
Precision Business Insights (PBI)

US$ 4,400.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Biopsy Devices Market

Increase in the prevalence of various cancer diseases such as prostate, breast, and lung cancers, technological development of the biopsy devices, increase the adoption of integrated biopsy technologies, and lack of screening tests for the specific type of cancer are anticipated to drive the biopsy devices market over the forecast period. In addition, increase the awareness about the chronic diseases, rise in global geriatric population, increase in the preference for minimally invasive procedures, and growing importance of disease screening for early treatment expected to propel the biopsy devices market. However, a high cost of the biopsy devices, unfavourable reimbursement policies, stringent regulatory guidelines, and lack of skilled technicians might hamper the growth of Biopsy devices market.

The biopsy is a minimally invasive surgical process performed to remove the tissue from the body for the determination of presence or extent of diseases such as cancer and inflammatory conditions. Generally, the biopsy is carried by radiologists, surgeons, and interventional cardiologists to confirm the presence of disease. A biopsy can be carried for the majority of organs in the body with the aid of specific biopsy devices. The various types of biopsy devices include skin biopsy, shave biopsy, fine needle aspiration, excision and incision biopsy, and vacuum-assisted biopsy among others. Conventional biopsy devices are complimented with the advanced imaging technologies like stereotactic-guided biopsy, CT scan, MRI-guided, ultrasound-guided biopsy, and others. These devices are helping to perform the biopsies in critical areas such as liver, kidney, and lungs.

Biopsy devises market is segmented on the basis of device type, application, imaging technologies, and end user.

Based on the device type, biopsy devices market is segmented into the following:

Core biopsy devices
Core biopsy needles
Core biopsy guns
Needle-based biopsy devices
Vacuum-assisted biopsy devices
Needles
Guns
Aspiration biopsy needles
Others

Based on the application, biopsy devices market is segmented into the following:

Gastrointestinal biopsy
Lung
Liver
Breast biopsy
Gynaecological
Kidney
Others

Based on the imaging technologies, biopsy devices market is segmented into the following:

Ultrasound-guided biopsy
Stereotactic guided biopsy
CT scan
MRI guided biopsy
Others

Based on the end user, Biopsy devices market is segmented into the following:

Hospitals
Clinics
Diagnostic Centres

Biopsy devises market is growing at a significant CAGR due to increase in the prevalence of cancer around the globe. Technological advancements of biopsy devices and increase in the demand for biopsy devices in disease screening for early treatment propel the biopsy devices market. Acquisitions and mergers, collaborations, product and patent approvals, and product launches are key strategies followed by the players for increasing market revenue growth. For instance, in September 2014, Argon Medical Devices, Inc. acquired Promex Technologies, LLC for diversification of business segment into the soft-tissue biopsy devices. Similarly, in September 2015, MDxHealth acquired the NovioGendix for developing its product portfolio in the prostate cancer diagnosis. Furthermore, in January 2015, Intact Medical Corp. has received the FDA approval for its minimally invasive breast biopsy devices.

Geographically, Biopsy devices market is segmented into Europe, North America, Asia Pacific, Latin America, and the Middle East and Africa. The growth of North America in biopsy devices market is attributed to increase in R&D activities, technological advancements of biopsy devices, increase in the prevalence of cancer disease (As per National Cancer Institute, in 2016, about 1,685, 210 new cancer cases were diagnosed in the U.S. and approximately 595,690 people will die from cancer), and availability of skilled professionals expected to fuel the biopsy devices market in the region. Europe holds a major share owing to increase in the prevalence of cancer (As per WHO Europe statistics, in 2012, more than 3.7 Mn new cases and 1.9 Mn deaths occur each year due to cancer), rise in the healthcare expenditure, increase in the R&D activities, and rise in adoption of minimally invasive procedures are anticipated to drive the biopsy devices market in Europe region. Asia Pacific region is expected to exhibit significant growth over the forecast period due to increase in the geriatric population especially in Japan, China, and India, increase in the prevalence of various types of cancers, and rise in the medical tourism in Asia Pacific region might propel the biopsy devices market.

Some of the players in Biopsy devices market are Becton, Dickinson and Company (U.S.), Argon Medical Devices (U.S.), Cardinal Health, Inc. (U.S.), Boston Scientific Corporation (U.S.), Medtronic plc (Ireland), B. Braun Melsungen AG (Germany), Olympus Corporation (Japan), Hologic, Inc. (U.S.), SmartTarget Ltd. (U.K.), MDxHealth (Belgium), and Intact Medical Corporation (U.S.) to name a few.

In August 2017, Hologic launched Bravera a breast biopsy system used for real-time breast biopsy and verification

In September 2016, SmartTarget Ltd launched its CE marked biopsy device used in the diagnosis of prostate cancer in U.K.
1. EXECUTIVE SUMMARY

2. GLOBAL BIOPSY DEVICES MARKET INTRODUCTION

2.1. Global Biopsy Devices Market – Taxonomy
2.2. Global Biopsy Devices Market –Definitions
  2.2.1. Device
  2.2.2. Application
  2.2.3. Imaging Technology
  2.2.4. End-User

3. GLOBAL BIOPSY DEVICES MARKET DYNAMICS

3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Biopsy Devices Market Dynamics – Factors Impact Analysis
3.6. Global Biopsy Devices Market – Regulations
  3.6.1. U.S.
  3.6.2. Europe

4. GLOBAL BIOPSY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis

5. GLOBAL BIOPSY DEVICES MARKET, BY DEVICE, 2012 - 2016 AND FORECAST, 2017 - 2023

5.1. DNA polymerase
  5.1.1. Core biopsy devices
    5.1.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
    5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
    5.1.1.3. Market Opportunity Analysis
  5.1.2. Core biopsy needles
    5.1.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
    5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
    5.1.2.3. Market Opportunity Analysis
5.2. Core biopsy guns
  5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.2.3. Market Opportunity Analysis
5.3. Needle-based biopsy devices
  5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.3.3. Market Opportunity Analysis
5.4. Vacuum-assisted biopsy devices
  5.4.1. Needles
    5.4.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
    5.4.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
    5.4.1.3. Market Opportunity Analysis
  5.4.2. Guns
    5.4.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
    5.4.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
    5.4.2.3. Market Opportunity Analysis
5.5. Aspiration biopsy needles
  5.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.5.3. Market Opportunity Analysis
5.6. Others
  5.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.6.3. Market Opportunity Analysis

6. GLOBAL BIOPSY DEVICES MARKET FORECAST, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 - 2023

6.1. Gastrointestinal biopsy
  6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.1.3. Market Opportunity Analysis
6.2. Lung
  6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.2.3. Market Opportunity Analysis
6.3. Liver
  6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.3.3. Market Opportunity Analysis
6.4. Breast biopsy
  6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.4.3. Market Opportunity Analysis
6.5. Gynaecological
  6.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.5.3. Market Opportunity Analysis
6.6. Kidney
  6.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.6.3. Market Opportunity Analysis
6.7. Others
  6.7.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.7.3. Market Opportunity Analysis

7. GLOBAL BIOPSY DEVICES MARKET FORECAST, BY IMAGING TECHNOLOGY, 2012 - 2016 AND FORECAST, 2017 - 2023

7.1. Ultrasound-guided biopsy
  7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.1.3. Market Opportunity Analysis
7.2. Stereotactic guided biopsy
  7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.2.3. Market Opportunity Analysis
7.3. CT scan
  7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.3.3. Market Opportunity Analysis
7.4. MRI guided biopsy
  7.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.4.3. Market Opportunity Analysis
7.5. Others
  7.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.5.3. Market Opportunity Analysis

8. GLOBAL BIOPSY DEVICES MARKET FORECAST, BY END-USER, 2012 - 2016 AND FORECAST, 2017 - 2023

8.1. Hospitals
  8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.1.3. Market Opportunity Analysis
8.2. Clinics
  8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.2.3. Market Opportunity Analysis
8.3. Diagnostic Centres
  8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.3.3. Market Opportunity Analysis

9. GLOBAL BIOPSY DEVICES MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023

9.1. North America
  9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.1.3. Market Opportunity Analysis
9.2. Europe
  9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
  9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.3.3. Market Opportunity Analysis
9.4. Latin America
  9.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
  9.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.5.3. Market Opportunity Analysis
9.6. Global Biopsy Devices Market - Opportunity Analysis Index, By Device, By Application, By Imaging Technology, By End-User, and Region, 2017 – 2023

10. NORTH AMERICA BIOPSY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

10.1. Device Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  10.1.1. Core biopsy devices
    10.1.1.1. Core biopsy needles
    10.1.1.2. Core biopsy guns
  10.1.2. Needle-based biopsy devices
  10.1.3. Vacuum-assisted biopsy devices
    10.1.3.1. Needles
    10.1.3.2. Guns
  10.1.4. Aspiration biopsy needles
  10.1.5. Others
10.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  10.2.1. Gastrointestinal biopsy
  10.2.2. Lung
  10.2.3. Liver
  10.2.4. Breast biopsy
  10.2.5. Gynaecological
  10.2.6. Kidney
  10.2.7. Others
10.3. Imaging Technology Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  10.3.1. Ultrasound-guided biopsy
  10.3.2. Stereotactic guided biopsy
  10.3.3. CT scan
  10.3.4. MRI guided biopsy
  10.3.5. Others
10.4. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  10.4.1. Hospitals
  10.4.2. Clinics
  10.4.3. Diagnostic Centres
10.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  10.5.1. U.S.
  10.5.2. Canada
10.6. North America Biopsy Devices Market - Opportunity Analysis Index, By Device, By Application, By Imaging Technology, By End-User, and Country, 2017 – 2023
10.7. North America Biopsy Devices Market Dynamics – Trends

11. EUROPE BIOPSY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

11.1. Device Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  11.1.1. Core biopsy devices
    11.1.1.1. Core biopsy needles
    11.1.1.2. Core biopsy guns
  11.1.2. Needle-based biopsy devices
  11.1.3. Vacuum-assisted biopsy devices
    11.1.3.1. Needles
    11.1.3.2. Guns
  11.1.4. Aspiration biopsy needles
  11.1.5. Others
11.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  11.2.1. Gastrointestinal biopsy
  11.2.2. Lung
  11.2.3. Liver
  11.2.4. Breast biopsy
  11.2.5. Gynaecological
  11.2.6. Kidney
  11.2.7. Others
11.3. Imaging Technology Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  11.3.1. Ultrasound-guided biopsy
  11.3.2. Stereotactic guided biopsy
  11.3.3. CT scan
  11.3.4. MRI guided biopsy
  11.3.5. Others
11.4. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  11.4.1. Hospitals
  11.4.2. Clinics
  11.4.3. Diagnostic Centres
11.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  11.5.1. Germany
  11.5.2. UK
  11.5.3. France
  11.5.4. Spain
  11.5.5. Italy
  11.5.6. Russia
  11.5.7. Poland
  11.5.8. Rest of Europe
11.6. Europe Biopsy Devices Market - Opportunity Analysis Index, By Device, By Application, By Imaging Technology, By End-User and Country, 2017 – 2023
11.7. Europe Biopsy Devices Market Dynamics – Trends

12. ASIA-PACIFIC BIOPSY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

12.1. Device Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  12.1.1. Core biopsy devices
    12.1.1.1. Core biopsy needles
    12.1.1.2. Core biopsy guns
  12.1.2. Needle-based biopsy devices
  12.1.3. Vacuum-assisted biopsy devices
    12.1.3.1. Needles
    12.1.3.2. Guns
  12.1.4. Aspiration biopsy needles
  12.1.5. Others
12.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  12.2.1. Gastrointestinal biopsy
  12.2.2. Lung
  12.2.3. Liver
  12.2.4. Breast biopsy
  12.2.5. Gynaecological
  12.2.6. Kidney
  12.2.7. Others
12.3. Imaging Technology Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  12.3.1. Ultrasound-guided biopsy
  12.3.2. Stereotactic guided biopsy
  12.3.3. CT scan
  12.3.4. MRI guided biopsy
  12.3.5. Others
12.4. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  12.4.1. Hospitals
  12.4.2. Clinics
  12.4.3. Diagnostic Centres
12.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
  12.5.1. Japan
  12.5.2. China
  12.5.3. India
  12.5.4. ASEAN
  12.5.5. Australia & New Zealand
  12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Biopsy Devices Market - Opportunity Analysis Index, By Device, By Application, By Imaging Technology, By End-User and Country, 2017 – 2023
12.7. Europe Biopsy Devices Market Dynamics – Trends

13. LATIN AMERICA BIOPSY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

13.1. Device Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  13.1.1. Core biopsy devices
    13.1.1.1. Core biopsy needles
    13.1.1.2. Core biopsy guns
  13.1.2. Needle-based biopsy devices
  13.1.3. Vacuum-assisted biopsy devices
    13.1.3.1. Needles
    13.1.3.2. Guns
  13.1.4. Aspiration biopsy needles
  13.1.5. Others
13.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  13.2.1. Gastrointestinal biopsy
  13.2.2. Lung
  13.2.3. Liver
  13.2.4. Breast biopsy
  13.2.5. Gynaecological
  13.2.6. Kidney
  13.2.7. Others
13.3. Imaging Technology Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  13.3.1. Ultrasound-guided biopsy
  13.3.2. Stereotactic guided biopsy
  13.3.3. CT scan
  13.3.4. MRI guided biopsy
  13.3.5. Others
13.4. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  13.4.1. Hospitals
  13.4.2. Clinics
  13.4.3. Diagnostic Centres
13.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  13.5.1. Brazil
  13.5.2. Mexico
  13.5.3. Argentina
  13.5.4. Venezuela
  13.5.5. Rest of Latin America
13.6. Latin America Biopsy Devices Market - Opportunity Analysis Index, By Device, By Application, By Imaging Technology, By End-User, and Country, 2017 – 2023
13.7. Latin America Biopsy Devices Market Dynamics – Trends

14. MIDDLE EAST AND AFRICA BIOPSY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

14.1. Device Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  14.1.1. Core biopsy devices
    14.1.1.1. Core biopsy needles
    14.1.1.2. Core biopsy guns
  14.1.2. Needle-based biopsy devices
  14.1.3. Vacuum-assisted biopsy devices
    14.1.3.1. Needles
    14.1.3.2. Guns
  14.1.4. Aspiration biopsy needles
  14.1.5. Others
14.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  14.2.1. Gastrointestinal biopsy
  14.2.2. Lung
  14.2.3. Liver
  14.2.4. Breast biopsy
  14.2.5. Gynaecological
  14.2.6. Kidney
  14.2.7. Others
14.3. Imaging Technology Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  14.3.1. Ultrasound-guided biopsy
  14.3.2. Stereotactic guided biopsy
  14.3.3. CT scan
  14.3.4. MRI guided biopsy
  14.3.5. Others
14.4. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  14.4.1. Hospitals
  14.4.2. Clinics
  14.4.3. Diagnostic Centres
14.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  14.5.1. Gulf Cooperation Council (GCC) Countries
  14.5.2. Israel
  14.5.3. South Africa
  14.5.4. Rest of MEA
14.6. MEA Biopsy Devices Market - Opportunity Analysis Index, By Device, By Application, By Imaging Technology, By End-User and Country, 2017 – 2023
14.7. MEA Biopsy Devices Market Dynamics – Trends

15. COMPETITION LANDSCAPE

15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Disease Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  15.2.1. Becton, Dickinson and Company (U.S.)
  15.2.2. Argon Medical Devices (U.S.)
  15.2.3. Cardinal Health, Inc. (U.S.)
  15.2.4. Boston Scientific Corporation (U.S.)
  15.2.5. Medtronic plc (Ireland)
  15.2.6. B. Braun Melsungen AG (Germany)
  15.2.7. Olympus Corporation (Japan)
  15.2.8. Hologic, Inc. (U.S.)
  15.2.9. SmartTarget Ltd. (U.K.)
  15.2.10. MDxHealth (Belgium)
  15.2.11. Intact Medical Corporation (U.S.)

16. RESEARCH METHODOLOGY

17. KEY ASSUMPTIONS AND ACRONYMS


More Publications